(Q52276405)

28 April 2018

title

Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling. (English)

1 reference

28 April 2018

1 reference

1 reference

Sanwald-Ducray P

1

1 reference

28 April 2018

Dow J

series ordinal

2

1 reference

28 April 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

28 April 2018

published in

Xenobiotica

1 reference

28 April 2018

volume

27

1 reference

28 April 2018

page(s)

189-201

1 reference

28 April 2018

issue

2

1 reference

28 April 2018

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

First-time-in-human dose selection: allometric thoughts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Predicting the hepatic clearance of xenobiotics in humans from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies scaling and pharmacokinetic parameters of 3TC in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies scaling and comparisons in drug development and toxicokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Man versus beast: pharmacokinetic scaling in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Physiological parameters in laboratory animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Comparison of the pharmacokinetics of dolasetron and its major active metabolite, reduced dolasetron, in dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982597240686

21 January 2018

Identifiers

DOI

10.1080/004982597240686

1 reference

28 April 2018

PubMed ID

9058532

1 reference

28 April 2018